SGD Pharma (PRIVATE.SGDPHARMA)

Take Impact Assessment
Overall impact
A (82)

Commentary

SGD Pharma is a leader for overall positive impact. With an 'A' rating of 82.5 for overall impact (96th percentile compared to all companies), SGD Pharma ranks 4th out of 94 industry peers, behind Aptar, Smurfit Kappa and Graham Packaging, and ahead of IFCO Systems, PaperWorks, Sonoco Products and 87 others. On top material causes for SGD Pharma's industry (Industrial Goods), SGD Pharma performs well in Conflict Free Mineral Production (95.7 score), Disaster Readiness and Effective Aid (81.9), Technology Innovation (95.0) and 12 other causes where it received an 'A' score and performs poorly in Reduced Green House Gas Emissions (33.5 score) and Reduced Availability of Weapons (14.5).
... read full commentary
Less
Screens
Advertising
Alcohol
Alcohol - responsible marketing
Animal treatment
Anti-abortion support
Anti-Israel
Anti-personnel mines
Arctic drilling
Banned pesticides and chemicals
Biological and chemical weapons
Cannabis
Carbon emissions intensity
Child safety
Cluster munitions
Coal
Contraceptives
Deforestation - financing
Deforestation - supply chain
Depleted uranium
Discrimination controversies
Electrical utility
Endangered wildlife
Environmental controversies
EU sanctions list
Factory farming
Fast food
Firearms
Food commodity derivatives
For-profit health care
Fossil fuel
Fur
Gambling
Genetic engineering
Health-related controversies
Human rights controversies
Human trafficking
ILO Conventions
Interest-based products
Interest-bearing debt
Interest-bearing securities
Iran
Land use and biodiversity
Military contracting
Misleading communication
Modern slavery
Music
Myanmar
Non-sustainable palm oil
Norges Bank exclusion list
Northern Ireland (Macbride)
North Korea
No SBTI commitment
Nuclear
OECD Guidelines
Oil and gas
Opioid controversies
Oppressive governments
Palestinian human rights
Pharma controversies
Pork
Pornography
Predatory lending
Prison involvement
Privacy breaches
Pro-life
Russia
Single-use plastic
Stem cell research
Sudan
Sugar
Syria
Tar sands
Thermal coal
Tobacco
Tobacco - GICS
UK sanctions list
Undermining US elections
UN Global Compact
UN Guiding Principles
US OFAC sanctions list
Weapons
Impact
Cause PRIVATE.SGDPHARMA
Peer rank
Overall impact

Log in to view this information

Screens
Advertising
Alcohol
Alcohol - responsible marketing
Animal treatment
Anti-abortion support
Anti-Israel
Anti-personnel mines
Arctic drilling
Banned pesticides and chemicals
Biological and chemical weapons
Cannabis
Carbon emissions intensity
Child safety
Cluster munitions
Coal
Contraceptives
Deforestation - financing
Deforestation - supply chain
Depleted uranium
Discrimination controversies
Electrical utility
Endangered wildlife
Environmental controversies
EU sanctions list
Factory farming
Fast food
Firearms
Food commodity derivatives
For-profit health care
Fossil fuel
Fur
Gambling
Genetic engineering
Health-related controversies
Human rights controversies
Human trafficking
ILO Conventions
Interest-based products
Interest-bearing debt
Interest-bearing securities
Iran
Land use and biodiversity
Military contracting
Misleading communication
Modern slavery
Music
Myanmar
Non-sustainable palm oil
Norges Bank exclusion list
Northern Ireland (Macbride)
North Korea
No SBTI commitment
Nuclear
OECD Guidelines
Oil and gas
Opioid controversies
Oppressive governments
Palestinian human rights
Pharma controversies
Pork
Pornography
Predatory lending
Prison involvement
Privacy breaches
Pro-life
Russia
Single-use plastic
Stem cell research
Sudan
Sugar
Syria
Tar sands
Thermal coal
Tobacco
Tobacco - GICS
UK sanctions list
Undermining US elections
UN Global Compact
UN Guiding Principles
US OFAC sanctions list
Weapons
Impact trend

Change in rating for overall impact

Log in to view this information

Company
Founded
1896
Employees
3,223
Sector
Materials
Industry
Containers & Packaging
Sub-industry
Metal, Glass & Plastic Containers
SASB industry
Containers & Packaging
Headquarters
France
Share classes
PRIVATE.SGDPHARMA
More info
www.sgd-pharma.com
Description
Developer of primary glass packaging products intended to serve the pharmaceutical industry. The company offers a broad range of sizes and finishes in Type I, II, or III, amber and clear glass, as well as added-value services like internal siliconization or protective plastic coatings. These features enable companies to get a broad range of products with customization options.
Material causes
Ethos considers the following causes material for SGD Pharma, based on its industry sub-industry Metal, Glass & Plastic Containers. Learn more about material causes in our methodology overview.
Not available

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.
OK
OK, I agree
No thanks